Author:
Maehara Yoshihiko,Oki Eiji,Ota Mitsuhiko,Harimoto Norifumi,Ando Koji,Nakanishi Ryota,Kawazoe Tetsuro,Fujimoto Yoshiaki,Nonaka Kentaro,Kitao Hiroyuki,Iimori Makoto,Makino Kunio,Takechi Teiji,Sagara Takeshi,Miyadera Kazutaka,Matsuoka Kazuaki,Tsukihara Hiroshi,Kataoka Yuki,Wakasa Takeshi,Ochiiwa Hiroaki,Kamahori Yoshihiro,Tokunaga Eriko,Saeki Hiroshi,Yoshizumi Tomoharu,Kakeji Yoshihiro,Shirabe Ken,Baba Hideo,Shimada Mitsuo
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Hematology,General Medicine,Surgery
Reference70 articles.
1. Heidelberger C, Chaudhuri NK, Danneberg P et al (1957) Fluorinated pyrimidines, a new class of tumour-inhibitory compounds. Nature 179(4561):663–666
2. Giller SA, Zhuk RA, Lidak MY (1967) Analogues of pyrimidine nucleosides I N1-(alpha-furanidyl) derivatives of natural pyrimidine bases and their antimetabolities. Dokl Akad Nauk SSSR 176(2):332–335
3. Toide H, Akiyoshi H, Minato Y et al (1977) Comparative studies on the metabolism of 2-(tetrahydrofuryl)-5-fluorouracil and 5-fluorouracil. Gann 68(5):553–560
4. Ikeda K, Yoshisue K, Matsushima E et al (2000) Bioactivation of tegafur to 5-fluorouracil is catalyzed by cytochrome P-450 2A6 in human liver microsomes in vitro. Clin Cancer Res 6(11):4409–4415
5. Inokuchi K, Hattori T, Taguchi T et al (1984) Postoperative adjuvant chemotherapy for gastric carcinoma. analysis of data on 1805 patients followed for 5 years. Cancer 53(11):2393–2397